CHI3L1 and myeloid sarcoma: This hypothesis was confirmed by the study of Cubas-Núñez et al. [97], who analysed the CSF CHI3L1 levels in different MS patients and evaluated the CHI3L1 expression and the degree of inflammation and neurodegeneration found in the autopsy tissue of 22 MS patients.